Diadema Partners Lp Portfolio Stock Holdings
According to the SEC 13F filed on August 14, 2026, Diadema Partners Lp disclosed 73 stock positions valued at approximately $283.17M as of quarter-end June 30, 2026. The largest holdings include UNITED THERAPEUTICS CORP DEL, REVOLUTION MEDICINES INC, and ABIVAX SA.
- Report Period
- June 30, 2026
- No. of Stocks
- 73
- Portfolio Value
- $283.17M
Holdings by Sector
Diadema Partners Lp Portfolio Holdings in Q2 2026
| Company | Symbol | Sector | Portfolio % | Shares | Change (Shares) | Change % | Value |
|---|---|---|---|---|---|---|---|
| UNITED THERAPEUTICS CORP DEL | UTHR | Healthcare | 10.14% | 52,989 | +25,686 | +94.08% | $28,711,030 |
| REVOLUTION MEDICINES INC | RVMD | Healthcare | 9.21% | 139,218 | +58,346 | +72.15% | $26,072,747 |
| ABIVAX SA | ABVX | Healthcare | 7.63% | 163,644 | +87,700 | +115.48% | $21,598,038 |
| COGENT BIOSCIENCES INC | COGT | Healthcare | 6.75% | 493,664 | +170,900 | +52.95% | $19,104,797 |
| BIOMARIN PHARMACEUTICAL INC | BMRN | Healthcare | 6.32% | 312,846 | +164,617 | +111.06% | $17,901,048 |
| VIKING THERAPEUTICS INC | VKTX | Healthcare | 6.09% | 441,808 | -83,373 | -15.88% | $17,234,930 |
| EDGEWISE THERAPEUTICS INC | EWTX | Healthcare | 3.91% | 272,214 | +242,214 | +807.38% | $11,060,055 |
| KODIAK SCIENCES INC | KOD | Healthcare | 3.00% | 218,117 | +25,155 | +13.04% | $8,497,838 |
| IMMUNOCORE HLDGS PLC | IMCR | Healthcare | 2.86% | 254,863 | +61,674 | +31.92% | $8,091,900 |
| 4D MOLECULAR THERAPEUTICS IN | FDMT | Healthcare | 2.68% | 571,107 | +571,107 | +100.00% | $7,595,723 |
| ARCUS BIOSCIENCES INC | RCUS | Healthcare | 2.44% | 223,810 | -14,332 | -6.02% | $6,900,062 |
| JOHNSON & JOHNSON | JNJ | Healthcare | 1.97% | 22,000 | -31,771 | -59.09% | $5,587,340 |
| NOVO-NORDISK A S | NVO | Healthcare | 1.70% | 100,000 | +85,423 | +586.01% | $4,809,442 |
| CORVUS PHARMACEUTICALS INC | CRVS | Healthcare | 1.56% | 294,811 | +50,000 | +20.42% | $4,404,476 |
| RELAY THERAPEUTICS INC | RLAY | Healthcare | 1.52% | 230,677 | +230,677 | +100.00% | $4,315,967 |
| ZYMEWORKS INC | ZYME | Healthcare | 1.31% | 142,132 | - | - | $3,715,330 |
| BIOAGE LABS INC | BIOA | Other | 1.27% | 146,334 | +86,334 | +143.89% | $3,586,646 |
| TAYSHA GENE THERAPIES INC | TSHA | Healthcare | 1.26% | 522,619 | +522,619 | +100.00% | $3,559,035 |
| NURIX THERAPEUTICS INC | NRIX | Healthcare | 1.04% | 121,539 | +121,539 | +100.00% | $2,948,536 |
| CORBUS PHARMACEUTICALS HLDGS | CRBP | Healthcare | 1.00% | 301,264 | -138,693 | -31.52% | $2,825,856 |
| INDIVIOR PHARMACEUTICALS INC | INDV | Other | 0.98% | 67,512 | -3,864 | -5.41% | $2,770,017 |
| INVENTIVA SA | IVA | Other | 0.96% | 740,786 | +388,387 | +110.21% | $2,725,718 |
| ORUKA THERAPEUTICS INC | ORKA | Other | 0.93% | 27,799 | +27,799 | +100.00% | $2,645,631 |
| VAXCYTE INC | PCVX | Healthcare | 0.93% | 45,071 | +20,000 | +79.77% | $2,619,977 |
| RELMADA THERAPEUTICS INC | RLMD | Healthcare | 0.88% | 361,367 | +160,525 | +79.93% | $2,500,660 |
| VERA THERAPEUTICS INC | VERA | Healthcare | 0.87% | 57,608 | +57,608 | +100.00% | $2,471,959 |
| CONTINEUM THERAPEUTICS INC | CTNM | Healthcare | 0.69% | 119,733 | +119,733 | +100.00% | $1,962,424 |
| BICYCLE THERAPEUTICS PLC | BCYC | Healthcare | 0.69% | 462,724 | -13,700 | -2.88% | $1,961,950 |
| MONTE ROSA THERAPEUTICS INC | GLUE | Healthcare | 0.67% | 78,391 | -108,916 | -58.15% | $1,897,062 |
| VIRIDIAN THERAPEUTICS INC | VRDN | Healthcare | 0.65% | 100,000 | +78,886 | +373.62% | $1,837,000 |
Showing 30 of 73 holdings in the latest reporting period.
Diadema Partners Lp Options Holdings in Q2 2026
| Quarter | Symbol | Company | Option | Contracts | Notional Value |
|---|---|---|---|---|---|
| Q2 2026 | VKTX | Viking Therapeutics, Inc. | CALL | 1,220,800 | $47,623,408 |
| Q2 2026 | ABVX | Abivax SA | CALL | 349,200 | $46,534,392 |
| Q2 2026 | BMY | Bristol-Myers Squibb Company | CALL | 600,000 | $34,572,000 |
| Q2 2026 | ABVX | Abivax SA | PUT | 252,400 | $33,634,824 |
| Q2 2026 | BMY | Bristol-Myers Squibb Company | PUT | 330,600 | $19,049,172 |
| Q2 2026 | CORT | Corcept Therapeutics Incorporat | CALL | 206,300 | $17,937,785 |
| Q2 2026 | KYMR | Kymera Therapeutics, Inc. | CALL | 149,700 | $17,166,099 |
| Q2 2026 | NVS | Novartis AG | PUT | 100,000 | $15,672,000 |
| Q2 2026 | QURE | uniQure N.V. | PUT | 299,000 | $13,771,940 |
| Q2 2026 | VKTX | Viking Therapeutics, Inc. | PUT | 350,500 | $13,673,005 |
| Q2 2026 | BIIB | Biogen Inc. | CALL | 60,000 | $12,963,600 |
| Q2 2026 | CAPR | Capricor Therapeutics, Inc. | PUT | 534,400 | $12,868,352 |
| Q2 2026 | SMMT | Summit Therapeutics Inc. | CALL | 860,200 | $12,533,114 |
| Q2 2026 | LLY | Eli Lilly and Company | PUT | 10,000 | $11,994,300 |
| Q2 2026 | INCY | Incyte Corporation | PUT | 105,400 | $11,948,144 |
| Q2 2026 | QURE | uniQure N.V. | CALL | 235,400 | $10,842,524 |
| Q2 2026 | BNTX | BioNTech SE | CALL | 100,000 | $9,305,000 |
| Q2 2026 | CAPR | Capricor Therapeutics, Inc. | CALL | 329,300 | $7,929,544 |
| Q2 2026 | NVS | Novartis AG | CALL | 50,000 | $7,836,000 |
| Q2 2026 | REPL | Replimune Group, Inc. | CALL | 696,300 | $7,708,041 |
| Q2 2026 | KOD | Kodiak Sciences Inc | CALL | 196,700 | $7,663,432 |
| Q2 2026 | MRNA | Moderna, Inc. | PUT | 100,000 | $7,003,000 |
| Q2 2026 | HIMS | Hims & Hers Health, Inc. | CALL | 200,000 | $6,934,000 |
| Q2 2026 | HIMS | Hims & Hers Health, Inc. | PUT | 193,700 | $6,715,579 |
| Q2 2026 | CRBP | Corbus Pharmaceuticals Holdings | CALL | 633,800 | $5,945,044 |
| Q2 2026 | SLS | SELLAS Life Sciences Group, Inc | CALL | 400,000 | $5,904,000 |
| Q2 2026 | KOD | Kodiak Sciences Inc | PUT | 146,900 | $5,723,224 |
| Q2 2026 | ALMS | Alumis Inc. | CALL | 200,000 | $5,628,000 |
| Q2 2026 | RPRX | Royalty Pharma | CALL | 100,000 | $5,607,000 |
| Q2 2026 | REPL | Replimune Group, Inc. | PUT | 502,500 | $5,562,675 |
Showing 30 of 70 options positions in the latest reporting period.
Notional value represents the total exposure of the options position.